

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Current price $20.95
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Sep 16, 26 |
Daily · Wilder smoothing
| Argus Research |
| maintain |
| Hold |
| Hold |
| Aug 27, 26 | Barclays | maintain | Equal Weight | Equal Weight |
| Aug 27, 26 | UBS | maintain | Neutral | Neutral |
| Aug 27, 26 | Baird | maintain | Neutral | Neutral |
| Aug 27, 26 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Aug 27, 26 | Wells Fargo | maintain | Overweight | Overweight |
| Aug 18, 26 | JP Morgan | maintain | Neutral | Neutral |
| Aug 18, 26 | Citigroup | upgrade | Neutral | Buy |
| Jul 28, 26 | Jefferies | maintain | Hold | Hold |
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 65.08 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 91.33 | Oscillator | Sell |
| Williams %R (14) | -14.26 | Oscillator | Sell |
| MACD (12, 26, 9) | 0.87 (Hist 0.41) | Oscillator | Strong Buy |
| Average Directional Index (14) | 25.84 (+DI 38.8 / -DI 13.6) | Trend | Strong Buy |
| EMA 20 | 19.09 | MA | Strong Buy |
| SMA 20 | 18.36 | MA | Strong Buy |
| EMA 50 | 18.67 | MA | Strong Buy |
| SMA 50 | 18.31 | MA | Strong Buy |
| SMA 200 | 19.82 | MA | Strong Buy |
FY2020 · 10-K disclosure
FY2024 · 10-K disclosure
TTM vs. 5-year historical average (annual ratios)
| Metric | BBWI | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 5.6x | 10.5x · sector 73.6x | Discount |
| Forward P/E (FY27E) | 7.8x | EPS est. 2.69 | Elevated |
| Price / Book | -4.0x | -6.0x | Discount |
| Price / Sales | 0.6x | 1.3x | Discount |
| EV / EBITDA | 5.5x | 8.1x | Discount |
| Return on equity | -61.8% | — | Weak |
| Gross margin | 44.1% | 44.7% | In line |
| Debt / Equity | -4.50 | -3.52 | Conservative |
| Piotroski / Altman Z | 7/9 | Z 2.34 | Grey zone |
Discounted cash flow model
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 4 | Oct 20, 2026 | 2026-10-20 17:42:47 | View |
| 4 | Sep 23, 2026 | 2026-09-23 16:52:12 | View |
| 8-K | Sep 23, 2026 | 2026-09-23 16:23:38 | View |
| 10-Q | Aug 26, 2026 | 2026-08-26 16:18:13 | View |
| 8-K | Aug 26, 2026 | 2026-08-26 07:17:10 | View |
| 4 | Aug 12, 2026 | 2026-08-12 16:35:03 | View |
| SC 13G/A | Aug 12, 2026 | 2026-08-12 08:22:29 | View |
| 3 | Jul 21, 2026 | 2026-07-21 16:37:20 | View |
| 8-K | Jul 20, 2026 | 2026-07-20 06:45:42 | View |
| 4 | Jun 15, 2026 | 2026-06-15 16:20:31 | View |
Proxy statement (DEF 14A) disclosures
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 16, 26 | Nash Sarah E | director | S-Sale | 1 @ $20.57 | $14 |
| Sep 21, 26 | Heaf Daniel | director, officer: CEO | A-Award | 591,366 | — |
| Aug 10, 26 | Aber Ann | officer: Chief Legal Officer &Corp Secy | A-Award | 12,940 | — |
| Jul 20, 26 | Aber Ann | officer | 0 | — | |
| Jun 11, 26 | Voskuil Steven E | director | A-Award | 7,970 | — |
| Jun 11, 26 | Rajlin Juan | director | A-Award | 7,970 | — |
| Jun 11, 26 | Symancyk James Kevin | director | A-Award | 7,970 | — |
| Jun 11, 26 | Lee Danielle M. | director | A-Award | 7,970 | — |
Stock news · updated daily
What You Should Know Bath & Body Works today opened its first Feel Good concept store in Charlotte, North Carolina, with Columbus, Ohio and Miami, Florida locations to follow this fall. Guided by consumer insights, the format pairs an open floorplan and clearer product information with hands-on testing and associate fragrance expertise.
Amid market uncertainty, five broker-favored stocks, CBRL, BBY, BZH, CLF and BBWI, stand out for earnings performance, growth initiatives & favorable valuations.
Bath & Body Works (BBWI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Bath & Body Works is leaning on upgraded formulas, packaging and new fragrances to support pricing as value-conscious consumers pressure broader sales.
Bath & Body Works (BBWI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Buyout sponsors hunt for cash flow, equity discounts, and operational levers that management left on the table.
Bath & Body Works (BBWI) reported earnings 30 days ago. What's next for the stock?
AGCO, BSX and BBWI have been added to the Zacks Rank #5 (Strong Sell) List on September 16th, 2026.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 26, 2026 | 0.24 | 0.62 | Beat 155.2% | $1.51B |
| May 27, 2026 | 0.29 | 0.32 | Beat 9.8% | $1.38B |
| Mar 4, 2026 | 1.77 | 2.05 | Beat 15.8% | $2.72B |
| Nov 20, 2025 | 0.38 | 0.35 | Miss -8.4% | $1.59B |
| Aug 28, 2025 | 0.37 | 0.37 | Beat 0.0% | $1.55B |
| May 29, 2025 | 0.42 | 0.49 | Beat 17.3% | $1.42B |